Sort   by:  
 Page size 
UnknownA biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.
Not available
S-EPMC6303732 | biostudies-literature
UnknownEfficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Not available
S-EPMC6581596 | biostudies-literature
UnknownNivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Not available
S-EPMC5744258 | biostudies-literature
UnknownMulticenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
Not available
S-EPMC11534537 | biostudies-literature
UnknownRandomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy.
Not available
S-EPMC5024018 | biostudies-literature
UnknownA Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.
Not available
S-EPMC4907409 | biostudies-literature
UnknownAssociation Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Not available
S-EPMC7580878 | biostudies-literature
UnknownFeasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).
Not available
S-EPMC4154478 | biostudies-literature
UnknownCombined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
Not available
S-EPMC5630525 | biostudies-literature
UnknownCryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
Not available
S-EPMC8322407 | biostudies-literature
Sort   by:  
 Page size